IMMG OTC
Immage Biotherapeutics Corp.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume1,000
Avg Volume933
Beta0.01
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOZhi Cong Mou
Employees3
SectorFinancial Services
IndustryFinancial - Conglomerates
IPO Date2022-12-02
Websiteimmagebio.com
10411 Motor City Drive
Bethesda, MD 20817
US
Bethesda, MD 20817
US
+1 301 560 5411
About Immage Biotherapeutics Corp.
Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States. Established in 2012, the entity was initially known as Epicure Charcoal, Inc., rebranding to Immage Biotherapeutics Corp. in June 2015. Its corporate headquarters are situated in Bethesda, Maryland, and it operates as a subsidiary of Coventry International Limited.
Latest News
No recent news
Recent Insider Trades
No insider trades found